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PRODUCTION OF ANTIMICROBIAL COMPOUNDS FROM A LOCAL MARINE 
BACTERIAL ISOLATE, BACILLUS SP. (S1A4) 
 
ABSTRACT 
 
A total of 160 strains of marine microorganisms were supplied by the 
Fisheries Research Institute, Penang. They were collected and isolated from 
samples all over the shores of Malaysia. Out of those, 134 were bacterial 
isolates, 9 actinomycetes, 3 fungal strains and 14 yeasts. A number of 113 
isolates were found to produce pigments. Non – pigmented strains (white 
colonies) were the most commonly found (26%) while the yellow coloured strains 
followed with a close second (25%), orange pigmented isolates (16%), and the 
rest were brown, beige, light green, dark blue, red, grey and transparent isolates 
in a small percentage. Among the marine isolates provided, only 88 isolates 
were tested for antimicrobial activity. 59.1% exhibited antimicrobial activity (52 
isolates) of which, 50.0% (42 isolates) exhibited antibacterial activity, 10.3% (9 
isolates) antifungal activity and 10.3% (9 isolates) exhibited both antibacterial 
and antifungal activities. The distribution of the antimicrobial compounds in the 
three selected isolates showed that all of them produced both extracellular and 
cell – bound antimicrobial compounds. The isolate S1A4 was chosen for further 
experiments because it exhibited a wide spectrum of activity, was easily 
subcultured and grew well in the cultivation medium. The isolate S1A4 was later 
on identified as the genus Bacillus sp.. The production of antimicrobial 
compounds was enhanced by optimizing the physical (culture conditions) and 
physiological (medium compositions) conditions. The optimized cultural 
 xix
conditions were: 150 rpm for the agitation speed, 4% (v/v) of 3 x 108 cells/ml of 
the inoculum size, initial pH medium of 7.3 and the incubation temperature was 
fixed at 37°C. About 50ml of filtered natural sea water was used in making the 
cultivation medium which consisted of 0.40% (w/v) of starch, 0.50% (w/v) of 
peptone, 0.20% (w/v) of yeast extract, 0.01% (w/v) of ferric phosphate, 0.09% 
(w/v) of L-arginine and 0.05% of KCl. Even though the production of 
antimicrobial compounds started during its exponential growth phase, maximum 
production was achieved during the idiophase. After optimization using the 
shake flask system, there was an increase of 29.6 U/ml or 39.6% increase in 
antimicrobial compound production. After optimization in the shake flask system, 
a tubular airlift fermenter with 2.0L capacity was used for scaling up and all the 
parameters were reoptimized. The optimized conditions were : 4 l/min of 
aeration, 4% (v/v) (3 x 108 cells per ml) of initial inoculum size and initial pH of 
7.3. About 1.8L of filtered natural sea water was used in making the medium 
which consisted of : 0.5% (w/v) of starch, 0.6% (w/v) peptone, 0.2% (w/v) of 
yeast extract, 0.01% (w/v) ferric phosphate, 0.09% (w/v) of L-arginine and 0.05% 
of KCl. An increment of 13.8% (4.1 U/ml) in antimicrobial compound production 
was obtained after optimization in a tubular airlift fermenter. Characterization of 
the crude extract found that it was thermostable in a temperature range between 
35°C – 65°C, and the pH stable at the pH values between pH 6 – pH 10. The 
antimicrobial compounds exhibited bactericidal activity against the cells of 
Staphylococcus aureus. SEM and TEM micrographs showed that the 
antimicrobial compound lysed the cell wall of S. aureus besides interfering the 
internal structure of the cells. 
 
 xx
PENGHASILAN SEBATIAN ANTIMICROB DARIPADA SATU PENCILAN 
MARIN BAKTERIA TEMPATAN, BACILLUS SP. S1A4. 
 
ABSTRAK 
 
Sejumlah 160 pencilan mikroorganisma marin telah dibekalkan oleh 
Institut Penyelidikan Perikanan, Pulau Pinang. Daripada jumlah tersebut, 134 
adalah pencilan bakteria, 9 aktinomiset, 3 kulat, and 14 yis. Sebanyak 113 
pencilan didapati menghasilkan pigmen. Pencilan yang tidak berpigmen (koloni 
putih) adalah yang paling banyak ditemui (26%), diikuti rapat dengan pencilan 
berpigmen kuning (25%), berpigmen jingga (16%), dan terlebihnya adalah 
perang, kuning keperangan, hijau muda, biru gelap, merah, kelabu dan lutsinar 
dalam peratusan yang kecil. Daripada kesemua pencilan marin, hanya 88 
pencilan sahaja yang diuji aktiviti antimikrobnya. Didapati sebanyak 59.1% (52 
pencilan) menunjukkan aktiviti antimikrob, yang mana 50.0% (42 pencilan) 
menunjukkan aktiviti antibakteria, 10.3% (9 pencilan) menunjukkan aktiviti 
antikulat dan 10.3% (9 pencilan) menunjukkan kedua – dua jenis aktiviti. 
Taburan sebatian antimikrob pada ketiga – tiganya menghasilkan sebatian 
antimikrob secara ekstrasel dan juga terikat pada sel. Pencilan S1A4 telah 
dipillih untuk kajian selanjutnya kerana ia mempamerkan spektrum aktiviti yang 
luas, tahan disubkultur dan dapat tumbuh dengan baik di dalam medium 
pengkulturan. Pencilan S1A4 telah dikenal pasti sebagai Bacillus sp. 
Penghasilan sebatian antimikrob oleh Bacillus sp. S1A4 telah ditingkatkan 
dengan mengoptimumkan keadaan fizikal (keadaan pengkulturan) dan fisiologi 
(komposisi medium) pengkulturannya. Keputusan pengoptimuman di dalam 
 xxi
sistem kelalang goncangan yang didapati adalah; kelajuan goncangan sebanyak 
150 psm, 4% (v/v) daripada 3 x 108 sel/ml untuk saiz inokulum, pH awal medium 
adalah sebanyak 7.3 dan suhu eraman pada 37°C. Sebanyak 50ml air laut 
semulajadi digunakan dalam pembuatan medium yang mengandungi 0.40% (b/i) 
kanji, 0.50% (b/i) pepton, 0.20% (b/i) ekstrak yis, 0.01% (b/i) of ferum fostat, 
0.09% (b/i) L-arginine dan 0.05% (b/i) KCl. Penghasilan sebatian antimikrob 
Bacillus sp. S1A4 dicapai pada peringkat idiofasa. Selepas pengoptimuman 
didalam sistem kelalang goncangan dilakukan, terdapat peningkatan dalam 
penghasilan sebatian antimikrob, iaitu peningkatan sebanyak 29.6 U/ml atau 
peningkatan sebanyak 39.6%. Selepas kajian pengoptimuman di dalam sistem 
kelalang goncangan lengkap dilakukan, pengoptimuman di dalam fermenter  
angkut udara tubular dengan keupayaan 2.0L dilakukan untuk skala besar.  
Keadaan optimum yang diperolehi adalah : untuk pengkulturan fizikal  
dalam fermenter adalah : pengudaraan sebanyak 4.0 l/min, 4% (i/i; 3 x 108 
sel/ml) saiz inokulum dan pH awal medium sebanyak 7.3. Sebanyak 1.8L air laut 
semulajadi yang telah dituras digunakan dalam pembuatan medium yang 
mengandungi 0.50% (b/i) of kanji, 0.60% (b/i) pepton, 0.20% (b/i) ekstrak yis, 
0.01% (b/i) of ferum fostat, 0.09% (b/i) L-arginine dan 0.05% (b/i) KCl. 
Peningkatan sebanyak 4.1 U/ml atau 13.8% dalam penghasilan sebatian 
antimikrob telah diperolehi. Pencirian ekstrak kasar sebatian ini menunjukkan 
bahawa sebatian ini bersifat thermostabil pada julat suhu 35°C – 65°C dan stabil 
pH pada julat antara pH 6 -10. Sebatian aktif antimikrob ini menunjukkan kesan 
bakterisid pada sel Staphylococcus aureus. Mikrograf SEM dan TEM 
menunjukkan bahawa sebatian ini menglisiskan dinding sel S. aureus di 
samping mengganggu struktur dalaman sel. 
 xxii
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1.0 INTRODUCTION 
1.1 Bioactive secondary metabolites 
The antibiotics belong to a group of substances referred to as secondary 
metabolic products, i.e. substances that are produced by living organisms, 
and that appear to be unrelated to the main processes of growth and 
reproduction. Flowers, plants, animals, all produce secondary metabolites in 
the form of colours, perfumes, essential oils, herbs, spices, alkaloids, and 
many more. These natural products have produced vast and interesting 
literatures. Table 1.1 shows a few classes of organic compounds which are 
produced during secondary metabolism. These complex novel substances 
have been regarded as arising by chance, perhaps as a result of the 
shunting of surplus products into metabolic sidelines. The metabolic 
pathways that are used are due to its genetic factor, but the biosynthetic 
pathways that are taken during antibiotic production are most probably 
activated during certain periods of growth and also during the lag phase. 
One can say it is during ‘stressful’ times like the attack of other organisms or 
other internally generated hazards that the production of these bioactive 
secondary metabolites swings into action (Calam, 1987). However it must be 
noted that secondary metabolites are not necessary for its survival. They do 
not serve vital roles in metabolism. It is unlikely that the complex systems of 
enzymes and genes required for this purpose exists without any plausible 
reason. Some of the possible roles include its ecological role in nature, as its 
acts in identification, attraction and repulsion of its own kind as well as 
others. Another possible function of secondary metabolism is to prevent the 
accumulation of primary metabolites during the resting phase that may prove 
harmful to the cell. Demain (1983) comments on the secondary metabolic 
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Table 1.1 : Classes of Organic Compounds Which Secondary Metabolites Are 
Found (Zahner & Maes, 1972) 
 
Amino sugars Lactones  Pyrones 
Anthocyanins Macrolides Pyrroles 
Anthraquinones Napthalenes Pyrrolines 
Aziridines Napthoquinones Pyrrolizines 
Benzoquinones Nucleosides Quinolines 
Coumarins Oligopeptides Quinolinols 
Diazines Phenazines Quinones 
Epoxides Phenoazinones Salicylates 
Ergoline alkaloids Phthaldehydes Terpenoids 
Flavonoids Piperazines Tetracyclines 
Glutaramides Polyacetylenes Tetronic acids 
Glycosides Polyenes Triazines 
Hydroxylamines Pyrazines Tropolones 
Indole derivatives Pyridines  
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products as antagonistic agents, symbiotic agents, sexual hormones, 
effectors of sporulation and germination, metal transporters, etc. that offer 
the producing organism an opportunity to survive in the competitive arena of 
nature. Their relation to differentiation is also stressed, as has been deduced 
by workers such as Bu’Lock (1975 ). 
 
1.2 The Importance of Continuing the Search for Novel Antibiotics  
Ever since the discovery of penicillin by a Scottish physician, 
Alexander Fleming in the year 1929, it quickly became a medical miracle, 
saving thousands by vanquishing the biggest wartime killer – infected 
wounds. Penicillin which was effective towards many microorganisms quickly 
became well known to be a ‘cure for all’ at that time, due to its effectiveness. 
He actually stumbled upon it, as it was a fungal contaminant on a 
plate streaked with Staphylococcus aureus. He noticed a clear zone all 
around the contaminant fungus, and realized the importance of a metabolite 
that could control bacterial growth as he had devoted much of his career to 
finding methods to treating infections. The substance was named penicillin, 
after the fungus, which was found to be Penicillium notatum. However, he 
could not purify this compound because of its instability, and it was not until 
the period of the Second World War (1939-1945) that two other British 
scientists, Florey and Chain, working in the USA, managed to produce the 
antibiotic on an industrial scale for widespread use. All three scientists 
shared the Nobel Prize for this work, and rightly so - penicillin rapidly 
became the "wonder drug" which saved literally millions of lives. It is still a 
"front line" antibiotic, in common use for some bacterial infections although 
the development of penicillin-resistance in several pathogenic bacteria now  
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 limits its effectiveness. 
The emergence of penicillin soon led to the finding of other antibiotic 
producing microorganisms, especially from soil. It was no surprise when the 
next antibiotic, streptomycin was discovered, it was from a soil actinomycete, 
Streptomyces griseus. Actinomycetes, especially from the genus 
Streptomyces yielded many clinically important antibiotics. Some of them are 
shown in Table 1.2. Other bacteria, including Bacillus species, have yielded 
few useful antibiotics. Fungi also have yielded few useful antibiotics. Apart 
from penicillin, the most important antibiotics from fungi are the 
cephalosporins (beta-lactams with similar mode of action to penicillin, but 
with less allergenicity) and griseofulvin (from Penicillium griseofulvum and 
related species) which is used to treat althlete's foot and related fungal 
infections of the skin.  
However, just after 4 years penicillin was mass produced, reports of 
microbes that was resistant to penicillin surfaced. The irony of it was that the 
first report of a microorganism that was resistant to penicillin was the very 
first microbe that led to the discovery of penicillin itself, S. aureus. This 
bacterium is often a harmless passenger in the human body, commonly 
carried on the skin and noses of healthy people, but it can cause illness, 
such as pneumonia or toxic shock syndrome, when it overgrows or produces 
a toxin. 
It has become resistant toward methicillin, an antibiotic commonly 
used to treat staphylococcal infections, thus becoming MRSA (Methicillin-
resistant Staphylococcus aureus.) The new strain has even become 
resistant to a few more antibiotics, and vancomycin, usually used as a last 
resort drug, had to be used (Lyon & Scurray, 1987). Even more disturbing,  
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Table 1.2 : Several Clinically Useful Antibiotics and their mode of 
actions  
 
Antibiotic Producer organism Activity Site or mode of 
action 
Penicillin Penicillium chrysogenum Gram-positive 
bacteria 
Inhibits the cell 
wall synthesis 
Cephalosporin Cephalosporium 
acremonium 
Broad spectrum Inhibits the cell 
wall synthesis 
Griseofulvin Penicillium griseofulvum Dermatophytic fungi Inhibits the 
microtubules 
Bacitracin Bacillus subtilis Gram-positive 
bacteria 
Inhibits the cell 
wall synthesis  
Polymyxin B Bacillus polymyxa Gram-negative 
bacteria 
Interfere the 
permeability of cell 
membrane 
Amphotericin B Streptomyces nodosus Fungi Interfere the 
permeability of cell 
membrane 
Erythromycin Streptomyces erythreus Gram-positive 
bacteria 
Inhibit protein 
synthesis 
Neomycin Streptomyces fradiae Broad spectrum Inhibit protein 
synthesis 
Streptomycin Streptomyces griseus Gram-negative 
bacteria 
Inhibit protein 
synthesis 
Tetracycline Streptomyces rimosus Broad spectrum Inhibit protein 
synthesis 
Vancomycin Streptomyces orientalis Gram-positive 
bacteria 
Inhibit protein 
synthesis 
Gentamicin Micromonospora purpurea Broad spectrum Inhibit protein 
synthesis 
Rifamycin Streptomyces mediterranei Tuberculosis Inhibit protein 
synthesis 
 
This table was adapted from (Lancini & Lorenzetti, 1993) and Gross et al., 1995. 
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intestinal bacteria, eg.enterococci that are resistant to vancomycin has been                     
found. Another type of penicillin-resistant pneumonia, caused by 
Streptococcus pneumoniae and called pneumococcus, surfaced in a remote 
village in Papua New Guinea in the year 1967 and till now 25% of the strain 
has mutated to be resistant to multiple drugs. Resistance to 
fluoroquinolones, a newer class of drugs, also is on the rise.  
Antibiotic resistance spreads fast.  According to a report in the April 
28, 1994, New England Journal of Medicine, researchers have identified 
bacteria in patient samples that resist all currently available antibiotic drugs. 
Antibiotic resistance is acquired through genes: bacterial mutation, 
transformation and plasmid transference. The later is found to be the most 
dangerous as a single plasmid can harbour a slew of resistances. In 1968, 
12,500 people in Guatemala died in an epidemic of Shigella diarrhea. The 
microbe harboured a plasmid carrying resistances to four antibiotics. 
Besides natural occurrences, antibiotic resistance is also due to over use of 
antibiotics. Table 1.3 shows the different mechanisms employed by resistant 
bacteria towards various antibiotics.  
When a person takes an antibiotic, the drug kills the defenseless bacteria, 
selecting those that can resist it. These renegade bacteria then multiply, 
increasing their numbers a million fold in a day, thus becoming the 
predominant microorganism. When that happens, it takes over as the main 
cause of infection. The antibiotic does not technically cause the resistance, 
but allows it to happen by creating a situation where an already existing 
variant can flourish.  A patient can develop a drug-resistant infection either 
by contracting a resistant bug to begin with, or by having a resistant microbe 
emerge in the body once antibiotic treatment begins. Drug-resistant  
  7
Table 1.3 : Mechanisms of Resistance to Some Representative Antibiotics 
(Lancini and Lorenzetti, 1993) 
Antibiotic Type of resistance Location of 
genetic 
determinant 
Description of resistance mechanism 
β – lactam 
antibiotics 
1. Inactivation  
 
 
 
2. Alteration of site of 
    action 
 
3. Permeability 
4. Tolerance 
Extrachromosomal  
and Chromosomal 
 
 
Chromosomal 
 
 
Variable 
Unknown 
Β – Lactamases that open the β – lactam 
ring. 
Some specific for penicillins or  
cephalosporins, others do not distinguish  
between the two antibiotics. 
Resistance to all the β – lactams as a result 
of modified penicillin binding proteins  
(PBP’s). 
Alteration of porins 
Inhibition of growth by low antibiotic  
concentrations but no bactericidal effect 
even at  
high concentrations. 
Chloramphenicol 1. Inactivation 
2. Modification of site 
    of action 
Extrachromosomal 
Chromosomal 
Acetylation by an inducible enzyme 
Alteration of rRNA 23S 
Aminoglycosides 1. Inactivation 
 
2. Permeability 
3. Modification of site 
    of action 
Extrachromosomal 
 
Chromosomal 
Chromosomal 
N-Acetylation, phosphorylation, adenylation 
related to various inactivating enzymes. 
Energy deficiency, modification of porins 
Modification of RNA 
Streptomycin 1. Modification of site 
    of action 
2. Inactivation 
Chromosomal 
 
Extrachromosomal 
Alteration of the S12 protein in the 
ribosomal 
30S subunit and alteration of the 16 S 
rRNA 
Analogous to that of the other 
aminoglycosides 
Kasugamycin  Modification of site of 
action 
Chromosomal Alteration of the 16 S RNA of the ribosomal 
30 S subunit 
Erythromycin 1. Modification of site 
    of action 
2. Inactivation 
Chromosomal and 
extrachromosomal 
Extrachromosomal 
Alteration of proteins of the ribosomal 50 S  
subunit and methylation of the RNA 
Hydrolisis of lactone and consequent 
opening  
of the ring 
Rifamycins Modification of site  
of action 
Chromosomal Alteration in the β subunit of RNA 
polymerase 
Cycloserine Alteration of  
permeability 
Chromosomal Modification of the transport system of D- 
alanine and glycine, used by cycloserine 
Tetracyclines Alteration of 
 permeability 
Chromosomal Decreased transport efficiency 
Fosfomycin 1. Alteration of  
    permeability 
 
2. Inactivation 
Chromosomal 
 
 
Extrachromosomal 
Modification in the transport system of  
glycerophosphate or glucose-6-phosphate 
(used  
to transport fosfomycin) 
Inactivating intracellular enzyme (reaction 
not  
yet identified) 
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infections increase risk of death, and are often associated with prolonged 
hospital stays, and sometimes complications (Liu & Chambers, 2003). 
Another concern is the over usage of antibiotics for feeding of livestock. This 
nowadays is common as farmers use antibiotics not to cure, but as a 
prevention of diseases. The very same antibiotics, used by humans, and if 
not, antibiotics with the same mode of action has been over used and is 
vulnerable a million fold as it can help the development of resistance, which 
could then be passed onto human pathogens easily by the method 
mentioned above.  
Thus, it is extremely imperative that the search for newer and better 
antibiotics should be continued considering the dangers at hand. 
Microorganisms have long met the demand but the search has been 
expanded to include an environment which holds a tremendous potential, 
and that is the marine environment, and it will make a huge impact on the 
drug discovery process.  
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1.3 Classification of Antibiotics  
Antibiotics differ in sources of origin, chemical structures, physical 
properties, antimicrobial spectrum, mode of action, and at first glance may 
seem overwhelming to comprehend. Nevertheless, despite those 
differences, they may be categorized in different ways as well. Here the 
various ways of classifications, its methods and several drawbacks for each 
method will be reviewed thoroughly. 
  
1.3.1 Classification of Antibiotics based on Biosynthesis Pathway   
In terms of biogenesis, antibiotics are considered secondary 
metabolites. The study on the biosynthesis of antibiotics consists of 
identifying the   enzymatic reactions by which one of more primary 
metabolites are converted into the antibiotic molecule. These processes 
include the steps leading from the nutrients that are supplied to the cell to its 
end products. The enzyme reactions that lead to synthesis of antibiotics do 
not differ fundamentally from those that lead to synthesis of primary 
metabolites. In fact, it is reasonable to hypothesize that the enzymes that are 
needed in the synthesis of special metabolites evolved from those of general 
metabolism. However there may be exceptional cases like in antibiotics 
which contain a nitro group, a function that is never found in primary 
metabolism and that is derived through a special pathway of amine 
oxidation. The biosynthetic pathways from which antibiotics are formed can 
be divided into 3 major categories:  
a) Antibiotics derived from a single primary metabolite. The biosynthetic 
pathway consists of a series of reactions that modify the starting material in 
the same way as in synthesis of amino acids or nucleotides 
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b) Antibiotics derived from two or three different primary metabolites, which are 
modified and condensed to give a complex molecule. There are some 
analogous cases in primary metabolism in synthesis of certain coenzymes, 
such as folic acid or coenzyme A.  
c) Antibiotics derived from polymerization of several metabolites to give a basal 
structure that can be further modified by additional enzymes reactions. The 
four classes of antibiotics which are derived from polymerization processes 
are : 
• Polypeptide antibiotics – derived from a  condensation of amino acids 
through a process similar to polyketide synthesis.  
• Antibiotics built up of acetate – propionate units by polymerization 
mechanisms similar to those that give rise to fatty acids.  
• Terpenoid antibiotics – derived from acetate units through isoprenoid 
synthesis.  
• Aminoglycoside antibiotics – made thought condensation reactions 
similar to those that make polysaccharides. 
However it should be emphasized that the basal structure obtained by 
polymerization is usually modified by further reactions, even by addition of 
molecules made through other biosynthetic pathways. Glycoside antibiotics 
made by condensation of one or more sugars onto a molecule 
biosynthesized by pathways are particularly common.  
 
For the complete elucidation of a biosynthetic process, it ideally comprises 
of: 
1. Identification of the ‘building blocks, which is the primary metabolites from 
which the molecule is made 
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2. Isolation of intermediates of the pathway, whose structure may suggest a 
reasonable hypothesis as to the sequence of reactions. 
3. Identification of the enzymes that catalyze the single reactions  
4. Identification of the governing genes and determination of their 
sequence.  
There are a few methods usually used to gain information about the 
biosynthetic processes. They are the usage of tracer techniques, the 
identification of intermediate metabolites, the identification of the enzymes 
produced, and using genetic and recombinant DNA techniques.  
However, most microorganisms have a tendency to form a whole 
series of secondary metabolites of a certain type once the capacity for 
carrying out the reactions leading into a particular secondary branch has 
been developed. A few examples to illustrate this tendency toward 
multiplicity of related products are shown in Table 1.4. 
• Actinomycins. Each actinomycin – producing organism forms several 
actinomycins, all of which have the same phenoxazone chromophoric group 
but which differ from each other in their peptide chains.  
• Anthracyclines. Streptomyces purpurascens produces a large variety of 
rhodomycins, which differ from each other in the aglycone or in the sugar 
portion of the molecule. The same goes for Streptomyces galileus, which 
produces pyrromycins.  
• Polymyxins. Bacillus polymyxa produces an almost irresolvable mixture of 
closely related peptide antibiotics.  
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Table 1.4: Antibiotics Which Do Not Conform to the Rule of Specificity 
(Zähner & Maes, 1972) 
 
Antibiotic Producing organisms 
Cephalosporin Cephalosporium sp. 
Streptomyces sp. 
Citrinin Penicillium sp. 
Streptomyces sp. 
Fusidic acid (Ramycin) Fusidium sp. 
Cephalosporium sp. 
Mucor ramannianus 
Bovinocidin (Beta – nitropropioopic 
acid) 
Streptomyces sp. 
Aspergillus sp. 
Constituent of a glycoside in higher planes 
Various phenazines Streptomyces sp. 
Pseudomonas iodinum 
Nebularin (9-(B-D-riboturanosyl)-purine) Afaricus nebularis 
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1.3.2 Classification of Antibiotics based on Producer Organisms 
As the name states, this style of classification are based on the 
organism that produces the metabolite. Many attempts have been made to 
find out the exact reason why a particular strain has the all the advantages 
while another poorer strain has virtually no ability to defend itself. However 
this type of classification does have its advantages, and among them, is that 
all the differing types of antibiotics can just be put together under the name 
of the same species. A few observations have been made so far. Firstly, 
most of the antibiotics derived are products of the secondary metabolism of 
3 main groups of microorganisms: eubacteria, actinomycetes, and 
filamentous fungi. The actinomycetes produce far by the largest number as 
well as the greatest variety of known antibiotics. They have yielded more 
than 6000 substances. The lower fungi produce several kinds of secondary 
metabolites, which approximately 1500 types show antibiotic activity. The 
eubacteria (mainly bacilli and pseudomonads) too produce a fair number of 
antibiotics, which is around 1000. Another group, the myxobacteria, although 
little studied, too has revealed a high frequency of production.  
A relationship seems to exist between the taxonomic group of the 
producing organism and the biosynthetic pathway for its antibiotics. 
However, further research is needed to confirm this relationship. Some 
biosynthetic pathways of secondary metabolism occur generally (e.g. the 
capacity to activate and to condense amino acids to produce polypeptide 
antibiotics is found in eubacteria, actinomycetes and lower fungi). There are 
some biosynthetic pathways only present in certain groups (e.g. practically 
all the known secondary metabolites originating from terpene synthesis are 
produced by fungi). Even within the same family, there seems to be 
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differentiation. In actinomycetes, there seems to be biosynthetic 
differentiation where the biosynthesis of aminocyclitol – containing antibiotics 
(aminoglycosides) is found much more frequently in the genera 
Streptomyces and Micromonospora than in other genera of the order 
Actinomycetales. However all these observations have merely statistical 
observations and not absolute value (Lancini & Parenti, 1995). 
Nevertheless, its drawbacks are even heavier than its advantages. 
Many loopholes exist in this system, because a given strain can produce a 
group of structurally and biosynthetically related substances, and yet also 
produce unrelated antibiotics as well. Antibiotic production simply is not 
rigorously species – specific. A classic example is Streptomyces griseus. 
Different strains of the same species have the ability to produce completely 
different antibiotics. Streptomycin (an aminoglycoside), novobioicin (a 
glycoside with a complex aromatic moiety), cyclohexamide (aromatic 
structure derived from acetate), viridogrisein (a depsipeptide), griseoviridin 
(lactone), are just a few examples of the difference of structures of antibiotics 
which are produced. Table 1.4 further demonstrates the violation towards 
this ‘rule of specificity’. 
On the other hand, the same antibiotic molecule can be produced too 
by different taxonomical group. For example, cycloserine has been isolated 
from both a Streptomyces and a Pseudomonas strain and penicillin N is 
produced by both lower fungi Cephalosporium as well as streptomycetes.  
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1.3.3 Classification of Antibiotics based on Spectrum of Activity 
An antibiotic is an inhibitor of microbial populations, and the way a 
particular compound inhibits another microorganism can be used as another 
way to classify antibiotics. Antibiotics inhibit growth either reversibly 
(bacteriostatic), that is, its blocks the ability of the cells to replicate and divide 
without killing them, or irreversibly (bactericidal), in which case the cells are 
killed. For an antibiotic to affect the metabolism of a microbial cell, it must 
first, enter the cell and reach the site of action. Secondly, it must bind 
physically or a cellular structure (target molecule) is involved in a process 
essential for maintenance of cell growth or homeostasis. Lastly, it must 
completely inhibit the process in which that structure is involved. 
Antibiotics are classified according to the processes with which they 
interfere. They are commonly divided into the following groups.  
1. Inhibitors of cell wall synthesis. 
The inhibitors can be divided into 2 major categories, those that inhibit 
peptidoglycan synthesis or disrupt the formation and elongation of the 
cell wall structure, and those that inhibit synthesis or assembly of 
other cell wall components which is effective towards Gram negative 
bacteria. The vast majority of known cell wall synthesis inhibitors 
belong to the former. For the antibiotics which work on the fungal cell 
wall synthesis, they work by inhibiting chitin synthesis or by inhibiting 
glucan synthesis. These two are major components in the make up of 
a fungal cell wall. However chitin is not a major component in a yeast 
cell wall, but it plays an important role in morphogenesis.   
2. Inhibitors of the replication or transcription of genetic material. 
Under this category, there are many ways to inhibit another  
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microorganism. They are : 
• Inhibitors of replication and transcription of nucleic acid 
• Inhibitors of template functions of DNA 
• Inhibitors of replication enzymes 
• Inhibitors of RNA polymerase  
3. Inhibitors of protein synthesis 
These types of inhibitors act by different mechanisms and also at 
different stages. They are a large and diverse group of substances, 
some of which have important clinical applications. They can be 
conveniently divided into 3 subgroups according to their site of action: 
• Inhibitors of aminoacyl – tRNA formation 
• Inhibitors of ribosomal functions 
• Inhibitors of extraribosomal factors 
4. Inhibitors of cell membrane function. 
Both prokaryotic and eukaryotic cells are surrounded by a cell 
membrane that controls the bidirectional flow of substances. 
Antibiotics that act on the cell membrane can be divided into another 
two groups: 
• Inhibitors that disorganize the membrane structure, thus 
causing loss of cellular components 
• Inhibitors that act as carriers for specific ions, called 
ionophores, and cause either an abnormal accumulation or  
abnormal excretion of ions.  
However, generally these antibiotics are poorly selective, acting 
against both bacterial and eukaryotic cells, reflecting the considerable 
chemical and structural similarities of the cell membranes of different 
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organisms. As a consequence of this lack of specificity, they are usually too 
toxic to be given systemically and their use is limited to topical applications.  
5. Antimetabolites 
The term antimetabolite refers to a group of natural and synthetic 
substances, with very heterogeneous chemical structures and 
mechanisms of action. Generally, but not always, their chemical 
structures are analogous to those of the metabolites they antagonize. 
Antimetabolites are divided into two large groups on the basis of their 
mechanisms of action: 
• Inhibitors that are incorporated into ‘informational’ polymers 
such as DNA, RNA and proteins, in place of natural monomers  
resulting in alteration of information content 
• Inhibitors that stops the formation of essential metabolites 
In both cases, the antimetabolites generally have structures similar to 
those of natural metabolites, of which they are analogues, and interact with 
the enzyme site that normally recognizes the natural ligand. However the 
degree of inhibition depends on the relative affinity for the enzyme of the 
analog and the natural metabolite and on the ratio of their concentration. 
However, this type of classification too has its share of problems. For 
example, the in vitro results may differ from the in vivo results from the 
antibiotic’s mode of action. There are also compounds which have totally 
different chemical structures but yet exhibit a similar if not identical mode of 
action (e.g. macrolides (Erythromycin) and aminoglycosides (Streptomycin, 
Gentamicin) both inhibits protein synthesis by binding itself to ribosome. On 
the other hand, Gramicidin S has two types of mechanisms of inhibition, it 
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affects the membrane cell thus disrupting its selective permeability, and also 
disrupts the cells phosphorylative oxidation system.  
 
1.3.4 Classification of Antibiotics Based on Chemical Structure 
This attempt of classification tries to demonstrate the relationships 
that exist between their chemical structures and their biological properties, 
especially their anti - microbes activities, mechanisms of resistance and 
toxilogical profile. The study of relationships between chemical structure and 
biological activity consists of identifying the functional groups which will be 
used in the classification processes. This may involve examining the activity 
at the molecular level, for it is the basis of the structure – activity relationship 
(Lancini, 1982). However this classification can be unambiguously said to be 
the most rational type of them all. 
The chemical structures of the antibiotics are one of the most diverse 
among natural products. They cover almost all types of organic molecules, 
and not to mention those that are chemically modified to enhance its 
biological activities and to make it more suitable for clinical usage. No other 
area of the natural product field has been confronted with such novelty, 
variety, and complexity of structures. Antibiotic chemistry has recently 
undergone explosive growth due to the advancement of various isolation 
and structural determination methods.  
Antibiotics can be divided into a few large groups, and because it is 
so structurally diverse with chemical modifications coming into the picture 
and other novel metabolites, subdivisions within the group exists. The major 
groups according to Berdy (1980) are: 
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1.3.4.1 Amino acid and peptide antibiotics 
This family of microbial antibiotics derived from amino acids represent 
the largest group of compounds, with over 1000 individual antibiotics 
recorded till then. However, this number includes numerous macromolecular 
antibiotics and the number of relatively simple, lower molecular weight 
peptide antibiotics is about 800. This family covers all of the amino acid 
groups, peptide, protein type compounds and those heterocyclic compounds 
in which its structures are actually derived from amino acids by a simple 
cyclization reaction, e.g., β – lactams, diketopiperazines, aspergillic acid, 
and thiostrepton compounds. A great majority of the antibiotics in this family 
are cyclic or linear oligo – or polypeptides, substituted peptides, and protein 
– type compounds. Simultaneously with the wide spreading of peptides and 
proteins in nature, a great variety of microorganisms are able to produce 
peptide antibiotics. They are produced by different species of actinomycetes, 
bacteria and fungi. It is remarkable that Bacillus species produce almost 
exclusively peptide antibiotics. It must be mentioned, that a great number of 
peptide antibiotics are fully utilized in the fields of human and veterinary 
medicine, agriculture and biochemical research. The first ever antibiotic to be 
mass produced, penicillin too is a β – lactam antibiotic. However, the general 
medical importance of other peptide compounds is much less than that of 
either aminoglycosides or tetracyclines, mainly because of their undesirable 
side reactions, particularly renal toxicity. Presently, in medical practice only 
polymyxins and some antitumor and antitubercular compounds (actinomycin, 
bleomycin, cycloserin) are in wide range use. The sub families of this 
particular group will be listed down in Table 1.5. 
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1.3.4.2 Carbohydrate antibiotics 
This group too forms one of the most abundant groups of antibiotics and 
include many physiologically active and important substances. Their 
essential roles include the metabolism of the different types of cells. In 
nature they rarely occur in free form (sugars), more frequently in polymeric 
association (oligosaccharides, polysaccharides, homo or heteropolymers), 
and very often in association with other classes of compounds 
(glycoproteins, glycolipids, nucleotides, and various glycosides). These 
present compounds number around 500 to this date, including numerous 
very important antibiotics. In addition to the outstandingly important 
aminoglycoside antibiotics used in human therapy (streptomycin, gentamicin, 
kanamycin, neomycin, etc.) and aminocyclitols used in agriculture and 
veterinary medicine, there are numerous others important antibiotics in the 
family. All compounds in this family, except some polysaccharides, are 
produced by Eubacteriales, predominantly by Actinomycetales and to a 
lesser extend by Bacillus species. However, high frequency of allergic 
reactions has been reported, and by and by large numbers of resistant 
mutants too have been reported. Certain cases also cause deafness 
because it has a specific toxicity for the auricular apparatus that results in 
vestibular damage with alteration of equilibrium. 
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Table 1.5 : Classification of Antibiotic Compounds According to its Chemical 
Structure (Berdy, 1982) 
 
Main family of 
antibiotics 
Subfamily Important 
representatives 
Amino acids and 
peptides 
Amino acids derivatives Cycloserine 
Alanosin 
Penicillin 
Glitoxin 
Chaetocin 
 Homopeptides Netropsin 
Negamycin 
Gramicidin 
Bacitracin 
Viomycin 
 Heteromer peptides Polymyxin 
Amphomycin 
Thiostrepton 
Bleomycin 
Sideromycin 
 Peptolides Actinomycin 
Surfactin 
Etamycin 
Telomycin 
Valinomycin 
 Macromolecular 
peptides 
Nisin 
Pacibilin 
Bacteriocins 
Carbohydrates Pure saccharides Streptozotocin 
Soedomycin 
Glucans 
 Aminoglycosides Streptomycins 
Bluensomycin 
Neomycin 
Gentamicin 
Validamycin 
Fortimicin 
Sorbistin 
 Other glycosides Streptolin  
Vancomycin 
Chromomycin 
 Sugar derivatives Everninomicin 
Lincomycin 
Moenomycin 
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Table 1.5 : Classification of Antibiotic Compounds According to its Chemical 
Structure (Con’t. )(Berdy, 1982) 
 
Main family of 
antibiotics 
Subfamily Important 
representatives 
Macrocyclic lactone 
(lactam) 
Macrolides Erythromycin 
Leucomycin 
Tylosin 
Borrelidin 
 Polyene Mycotrienine 
Nystatin 
Rimocidin 
Eurocidin 
Candihexin 
Dermostatin 
 Macrocyclic lactones Oligomycin 
Primycin 
Boromycin 
Chlorothricin 
 Macrolactams Rifamycin 
Maytansin 
Viridenomycin 
Quinone and similar 
antibiotics 
Tetracyclics Tetracycline 
Rhodomycin 
Ayamycin 
 Napthoquinones Javanicin 
Granaticin 
Rubromycin 
 Benzoquinones Spinulosin 
Mitomycin 
 Quinone-like compounds Maytenin 
Epoxidon 
Heterocyclics Nitrogen containing 
heterocyclic compounds 
• Single heterocycles 
 
• Condensed 
heterocycles 
 
 
 
 
Pyrrolnitrin 
Blasticidins 
Pyocyanine 
Anthramycin 
Tubercidin 
Heterocyclics Oxygen-containing  
heterocyclic compounds 
• Small lactones 
 
 
• Polyether 
 
 
Acetomycin 
Penicillic acid 
Actinobolin 
Monensin 
Nigerisin 
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Table 1.5 : Classification of Antibiotic Compounds According to its Chemical 
Structure (Con’t.) (Berdy, 1982) 
 
 
Main family of 
antibiotics 
Subfamily Important 
representatives 
Alicyclic antibiotics Cycloalkane Sarcomycin 
Fumagillin 
Ketomycin 
Streptimidone 
 Small terpenes Coriolin 
Vernolepin 
 Oligoterpenes Fusidic acid 
Saponins 
Trichotecin 
Aromatic antibiotics Benzene derivatives Flavipin 
Chloramphenicol 
Xanthocyllin 
 Condensed aromatic  
compounds 
Griseofulvin 
Gossypol 
Orchinol 
 Non benzoid aromatic  
compounds 
 
Puberulic acid 
Lactaroviolin 
 Other aromatic derivatives Zinninol 
Novobiocin 
Nidulin 
Aliphatic antibiotics Alkane derivatives Elaiomycin 
 Carboxylic acid derivatives Mycomycin 
Eulicin 
 Sulfur and phosphor  
containing aliphatic  
compounds 
Fluopsin 
Phosphonomycin 
Allcin 
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1.3.4.3 Macrocyclic lactone (lactam) antibiotics 
Macrocyclic compounds are frequently occurring structural types 
among antibiotics. They can be classified as derivatives of long – chain 
aliphatic hydroxyl acids, forming internal lactone. Their specific and unique 
chemical and biological properties and their great importance require that 
they be discussed as a distinct group of antibiotics. Beside macrocyclic 
lactones and lactams, numerous large – ring cyclopeptides, 
cyclodepsipeptides, and a few carboxylic terpene derivatives are found in 
this group of natural products. Overall, there are to date about 1000 
antibiotic compounds found in this group. Among the microbial bioactive 
metabolites, macrocyclic lactone family are relatively abundant, as compared 
to other natural products. Among the macrocyclic lactone family, they have 
antifungal, antimicrobial, cytotoxic, cation – active biological activities. The 
compounds in this family are produced almost exclusively by various 
Actinomycetes, mainly Streptomyces species. Only some macrocyclic 
lactone derivatives (cytochalasins, brefeldin, etc.) are produced by fungi. So 
far, none of the bacterial species have been reported to produce this type of 
antibiotic. The maytansine type and lactams are produced by higher plants 
and Nocardia species. One of the positive side to this antibiotic is that the 
side effects are much less and usually slight. But, the principal problems with 
this class of antibiotics seem to be unsatisfactory absorption and the spread 
of resistant strains.  
 
1.3.4.4 Quinone and similar antibiotics 
Chemically quinones are diketones derived from dihydroaromatic 
compounds. Quinoid compounds are widely distributed in nature. Various 
